| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.40M | 121.40M | 128.20M | 112.10M | 143.40M | 21.20M |
| Gross Profit | 94.20M | 108.70M | 121.70M | 100.70M | 82.10M | 2.50M |
| EBITDA | 39.70M | 43.20M | 44.00M | 30.90M | 19.00M | -23.30M |
| Net Income | 3.40M | 8.60M | 13.00M | 10.10M | 1.60M | -30.20M |
Balance Sheet | ||||||
| Total Assets | 610.90M | 502.10M | 495.90M | 435.20M | 346.90M | 276.70M |
| Cash, Cash Equivalents and Short-Term Investments | 209.60M | 234.10M | 96.20M | 75.80M | 64.50M | 56.00M |
| Total Debt | 30.20M | 2.20M | 2.80M | 4.50M | 3.90M | 2.90M |
| Total Liabilities | 484.30M | 345.30M | 313.40M | 267.00M | 190.10M | 126.80M |
| Stockholders Equity | 126.60M | 156.80M | 182.50M | 168.20M | 156.80M | 149.90M |
Cash Flow | ||||||
| Free Cash Flow | -12.80M | 0.00 | 16.60M | 21.90M | 39.60M | 8.50M |
| Operating Cash Flow | 39.80M | 43.40M | 26.90M | 22.00M | 52.00M | 13.60M |
| Investing Cash Flow | -10.50M | -7.80M | -2.60M | -7.90M | -12.10M | -5.00M |
| Financing Cash Flow | -54.60M | -37.20M | -5.60M | -2.80M | -700.00K | 23.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.16B | 5.25 | 24.73% | 1.18% | 7.17% | -2.22% | |
65 Neutral | £1.39B | 7.62 | 6.41% | ― | 2.96% | 9.30% | |
64 Neutral | £213.01M | 62.17 | 2.40% | 1.39% | -1.97% | -77.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £136.24M | 22.53 | 9.72% | 0.60% | 3.16% | -21.30% | |
56 Neutral | £661.71M | 15.06 | -113.93% | 1.40% | 3.94% | ― | |
50 Neutral | £1.29B | -45.75 | -65.76% | 2.50% | 4.58% | -24.15% |